Literature DB >> 33566704

COVID-19 and the eye: a review.

Irving Armando Domínguez-Varela1, Luis Alberto Rodríguez-Gutiérrez1, Nallely Rubí Morales-Mancillas1, Maximiliano Barrera-Sánchez1, Yolanda Macías-Rodríguez1, Jorge Eugenio Valdez-García1.   

Abstract

BACKGROUND: To provide a review for general practitioners and medical specialists about the most common eye complaints and ocular manifestations in a COVID-19 patient.
METHODS: Reviewed 50 articles referenced in 4 databases from 20 December 2019 to 16 September 2020.
RESULTS: Of the 50 articles reviewed, 26 met the criteria for analysis and were included in the study. Among them were 5 reviews, 6 case series, 7 case reports, 4 cross-sectional studies, 2 systematic reviews, 1 cohort study and 1 correspondence. We found that the prevalence of ocular manifestations in patients during the course of COVID-19 varied between 0.8% and 31.6%, depending on the study design. Symptoms of acute conjunctivitis were the most frequent clinical findings. Acute phase reactants were also correlated to ocular manifestations and the severity of the systemic disease in many reports.
CONCLUSIONS: Ocular manifestations are not uncommon in COVID-19 patients and have been associated with higher levels of acute phase reactants as well as a higher degree of severity of the systemic disease. We recommend that all physicians consider COVID-19 as a differential diagnosis in the presence of acute conjunctivitis with or without systemic symptoms.

Entities:  

Keywords:  COVID-19; Novel coronavirus; differential diagnosis; ocular manifestations; ophthalmology; viral conjunctivitis

Year:  2021        PMID: 33566704     DOI: 10.1080/23744235.2021.1882697

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN: 2374-4243


  5 in total

Review 1.  A Systematic Literature Review and Bibliometric Analysis of Ophthalmology and COVID-19 Research.

Authors:  Ali Forouhari; Vahid Mansouri; Sare Safi; Hamid Ahmadieh; Amir Ghaffari Jolfayi
Journal:  J Ophthalmol       Date:  2022-05-24       Impact factor: 1.974

2.  Decreased incidence of acute hemorrhagic conjunctivitis associated with enhanced public health intervention during the COVID-19 epidemic in China, 2020.

Authors:  Li Zhang; Xiangyu Guo; Hui Jiang; Na Zhao; Wei Cheng; Wangli Xu; Shelan Liu
Journal:  Arch Virol       Date:  2022-01-18       Impact factor: 2.685

3.  Ophthalmological Care Management of Cataract Patients During the COVID-19 Times: Perspectives From a Mexican Eye Health Care System.

Authors:  Irving A Domínguez-Varela; Gustavo Ortiz-Morales; Daniela E Gómez-Elizondo; José A Nava-García; Jorge E Valdez-García
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2021-11-16

Review 4.  Long-COVID Syndrome and the Cardiovascular System: A Review of Neurocardiologic Effects on Multiple Systems.

Authors:  Nicholas L DePace; Joe Colombo
Journal:  Curr Cardiol Rep       Date:  2022-09-30       Impact factor: 3.955

Review 5.  Update on overview of ocular manifestations of COVID-19.

Authors:  Mitra Akbari; Maryam Dourandeesh
Journal:  Front Med (Lausanne)       Date:  2022-09-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.